PUBLISHER: Allied Market Research | PRODUCT CODE: 1266413
PUBLISHER: Allied Market Research | PRODUCT CODE: 1266413
The Non-PVC IV bags market valued for $880.21 million in 2021 and is estimated to reach $1,684.50 million by 2031, exhibiting a CAGR of 6.7% from 2022 to 2031.
Non-PVC IV bags are intravenous bags made up of non-polyvinyl chloride film. Non-PVC IV bags help reduce the risks associated with conventional IV bags, such as transportation issues and drug interactions with packaging and disposable containers. There is a rise in demand for non-PVC IV bags, which causes shift in the company's focus on manufacturing PVC-free bags due to the benefits provided by PVC-free IV bags. This is expected to propel the market growth. These bags are quite popular in oncology therapy due to the associated benefits such as less pollution, safety, compatibility, lightweight, convenience to use, and low risk of contamination.
The growth of the global non-PVC IV bags market is majorly driven by increase in demand for non-PVC IV bags, owing to increase in number of cardiac surgical procedures increases the demand for non-PVC IV bags for transporting the fluids. For instance, according to the World Health Organization (WHO), nearly 90% of Chronic Obstructive Pulmonary Disease (COPD) deaths under 70 years of aged occur in low- and middle-income countries (LMIC). Thus, increase in cardiac surgical procedures has led to increase in the demand for non-PVC IV bags, as these bags are providing intravenous fluids to cardiac patients and receiving treatment for acute exacerbations.
In addition, increase in cases of Hospital Acquired Infections (HAI), due to lack of sanitation is the factor responsible for the market growth. For instance, Centers for Disease Control (CDC), estimated that around 1.7 million hospital acquired infections and 99,000 associated deaths each year occurred in the U.S. Thus, rise in cases of Hospital Acquired Infections (HAI) require intravenous antibiotics for weeks thereby increasing the demand for non-PVC IV bags.
Furthermore, increase in awareness regarding non-PVC IV bags in developed countries such as the U.S. and rise in improved designs of non-PVC IV bags further fuel the market growth. However, high cost of non-PVC IV bags and inadequate training to hospital staff about disposal of non-PVC IV bags hinders the market growth. Conversely, increase in demand for non-PVC IV bags and rise in advanced features in non-PVC IV bags are anticipated to provide lucrative opportunities to the market players.
The non-PVC IV bags market is segmented into product type, material type, end user, and region. By product type, the market is categorized into single chamber and multi chamber. By material type, the market is segregated into polypropylene IV bags, polyethylene IV bag, and others. By end user, the market is classified into hospitals, ambulatory surgical centers, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major key players that operate in the global non-PVC IV bags market are: B. Braun SE, BAUSCH Advanced Technology Group, Fagron Sterile Services US, Fresenius SE & Co. KGaA, ICU Medical, Inc., JW Holdings, KRATON CORPORATION, MEDI PHARMA PLAN Co.,Ltd. Sippex IV bags, and Technoflex.